Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 926-771-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
The two selected inhalation studies were both performed on rats, that is considered to be the most relevant model for the evaluation of inhalation toxicity to humans, as the lungs of rats closely resemble the human lung.
The result from the studies show no significant carcinogenic potential for FMMVF fibres, thus it can be concluded that there is limited evidence of carcinogenic potential.
A Life-time inhalation study on rats, conclude that there is no statistical evidence for carcinogenicity of FMMVF fibers.
The other study with 12 month exposure and 12 month recovery, indicated that exposure to FMMVF can induce fibrosis at very high exposure concentrations. Also some, 10.5% of the animals exposed developed adenomas, but no mesotheliomas were observed in the exposed animals. It is concluded that FMMVF fibers did not induce carcinogenesis.
Key value for chemical safety assessment
Carcinogenicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 30 mg/m³
Justification for classification or non-classification
In the two selected studies on carcinogenicity, no significant evidence could be demonstrated. Both studies were chronic toxicity studies and therefore relevant for the evaluation of potential adverse effects on human health. A NOAEL for carcinogenesis was established on the basis of the data in McConnell et al. therefore FMMVF fibres can be considered a possible carcinogen with a threshold of concern, that is above the tested highest dose 30 mg per m3, corresponding to 243 WHO fibres per cm3.
Additional information
The fibre types tested in the two selected studies complies with the definiton of FMMVF fibres. The experimental setup, chronic inhalation animal model is considered the most relevant laboratory model for evaluating the potential risk of airborne fibres to human health. Also the experimental animal, rat is considered the most relevant animal for evaluating the potential risk of airborne fibres to human health.
In McConnell et al 1994, it was concluded from the study that in very high doses the MMVF 21 and MMVF 22 fibers give rise to increase in pulmonary macrophages as well as could be expected from exposure to any other inert/inorganic particulate, but in a reversible manner, when exposure is ceased. Occasional bronchoalveolar neoplasms were found in all dose groups, including the unexposed control. No mesotheliomas were observed in the fiber exposed groups, consequently there was no statistical evidence for a carcinogenic effects of the two fiber types studied.
The Cullen et al 2000 study came to similar conclusions as McConnell et al. Animals exposed to 100/475 fibers at 4 times the exposure concentration as in McConnell, had a slightly higher level of fibrosis, than did unexposed control animals, although it was not statistically significant. The 100/475 fiber did not induce any carcinomas or mesotheliomas. Adenomas were present in 4 out of 38 animals , corresponding to 10.5%, compared to 1 out of 38, corresponding to 2.6% in unexposed control. The study therefore shows that FMMVF fibers possibly can induce development of fibrosis and adenomas at very high exposure concentrations, but there is no significant evidence for tumor development following inhalation exposure to the fibers.
Carcinogenicity: via inhalation route (target organ): respiratory: lung
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.